I just bought into PTN because it has potential for a solid uptick over the next couple of months, especially with their compliance efforts underway and positive forecasts suggesting it could jump to $7 within the year. The price is low now, making it an appealing buy.

I've just bought PTN as it has reached an all-time low of 0.69, and with positive news about FDA approval for a rare type of obesity drug, I see potential for a rebound. The stock has shown patterns of bouncing back after dips, and I'm optimistic we could see it rise to around 0.85 soon.